Kura Oncology Logo
Kura Oncology to Host Virtual Investor Event on December 5, 2020
November 24, 2020 07:30 ET | Kura Oncology, Inc.
SAN DIEGO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Kura Oncology Logo
Kura Oncology Reports Second Quarter 2016 Financial Results
August 10, 2016 16:03 ET | Kura Oncology, Inc.
Promising clinical activity observed in Phase 2 trial of tipifarnib in HRAS mutant solid tumors has triggered additional patient enrollment Management to host webcast and conference call today at...
Kura Oncology to Present at the Jefferies 2015 Global Healthcare Conference
May 27, 2015 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...